Submission of Press Release that is being issue by Curateq Biologics s .r.o a wholly owned step down subsidiary of the Company in connection with the receipt of positive opinion from CHMP for Dazubys a Trastuzumab Biosimilar.
Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Press Release / Media Release
April 26, 2025
Download PDF
Aurobindo Pharma